Edita Navratilova, Ph.D.
Affiliations: | 2007 | University of Arizona, Tucson, AZ |
Google:
"Edita Navratilova"Mean distance: 16.06 (cluster 32) | S | N | B | C | P |
Parents
Sign in to add mentor| Henry I. Yamamura | grad student | 2007 | University of Arizona | |
| (Regulation of the human delta opioid receptor.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dogrul BN, Machado Kopruszinski C, Dolatyari Eslami M, et al. (2024) Descending facilitation from rostral ventromedial medulla mu opioid receptor-expressing neurons is necessary for maintenance of sensory and affective dimensions of chronic neuropathic pain. Pain |
| Navratilova E, Qu C, Ji G, et al. (2023) Opposing effects on descending control of nociception by mu and kappa opioid receptors in the anterior cingulate cortex. Anesthesiology |
| Kopruszinski CM, Watanabe M, Martinez AL, et al. (2022) Kappa opioid receptor agonists produce sexually dimorphic and prolactin-dependent hyperalgesic priming. Pain |
| Kopruszinski CM, Vizin R, Watanabe M, et al. (2022) Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors? The Journal of Headache and Pain. 23: 126 |
| Yakhnitsa V, Ji G, Hein M, et al. (2022) Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain. Frontiers in Pharmacology. 13: 903978 |
| Sato D, Narita M, Hamada Y, et al. (2022) Relief of neuropathic pain by cell-specific manipulation of nucleus accumbens dopamine D1- and D2-receptor-expressing neurons. Molecular Brain. 15: 10 |
| Hein M, Ji G, Tidwell D, et al. (2021) Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors. Neuropharmacology. 185: 108456 |
| Kopruszinski CM, Thornton P, Arnold J, et al. (2020) Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine. Cephalalgia : An International Journal of Headache. 333102420966581 |
| Chen Y, Navratilova E, Dodick DW, et al. (2020) An Emerging Role for Prolactin in Female-Selective Pain. Trends in Neurosciences |
| Navratilova E, Behravesh S, Oyarzo J, et al. (2020) Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache. Cephalalgia : An International Journal of Headache. 333102420938652 |